Amlodipine besylate interactions
Pro Research Analysisby 
Searched over 200M research papers
Amlodipine Besylate Interactions: A Comprehensive Overview
Introduction to Amlodipine Besylate
Amlodipine besylate is a widely used calcium channel blocker primarily prescribed for the treatment of hypertension and angina. Its interactions with other substances, including drugs, dietary supplements, and excipients, are crucial for optimizing therapeutic outcomes and minimizing adverse effects.
Drug-Drug Interactions
Amlodipine and Quercetin
Amlodipine besylate interacts with quercetin, a plant flavonoid, in the presence of human serum albumin (HSA). Both compounds bind to Sudlow’s Site 1 on HSA, leading to competitive interactions. Quercetin can displace amlodipine from its binding site, and the presence of amlodipine facilitates quercetin binding. This interaction suggests potential pharmacokinetic implications when these substances are co-administered .
Amlodipine and Benazepril
A pharmacokinetic study involving benazepril, an ACE inhibitor, and amlodipine besylate showed no significant interaction between the two drugs. The pharmacokinetic parameters such as AUC, Cmax, and Tmax for both benazepril and amlodipine remained consistent whether administered alone or in combination, indicating that these drugs can be co-administered without altering their pharmacokinetic profiles .
Amlodipine and Losartan
A fixed-dose combination of amlodipine besylate and losartan potassium was compared with a combination of amlodipine camsylate and losartan potassium. The pharmacokinetic profiles of both combinations were similar, and both were well tolerated by healthy subjects. This suggests that amlodipine besylate can be effectively combined with losartan for hypertension management without significant pharmacokinetic concerns .
Amlodipine and Celecoxib
A combination tablet of amlodipine besylate and celecoxib, a nonsteroidal anti-inflammatory drug, has been approved for patients with both hypertension and osteoarthritis. This combination offers benefits such as increased compliance and reduced cost. However, celecoxib may cause a variable degree of blood pressure increase, necessitating careful monitoring when these drugs are co-administered .
Drug-Excipients Interactions
Stability with Excipients
Amlodipine besylate's stability in solid dosage forms was evaluated with various excipients. Mixtures with lactose, magnesium stearate, and water induced some instability, leading to the formation of degradation products. Therefore, lactose-free formulations are recommended to ensure the safety and efficacy of amlodipine besylate .
Combination Therapies
Traditional Chinese Medicine
Combining amlodipine besylate with acupoint application of traditional Chinese medicine has shown promising results in treating renal failure and hypertension. This combination significantly reduced systolic and diastolic blood pressures and improved renal function markers. The therapeutic effects are likely mediated through the PI3K/AKT pathway, highlighting the potential of integrative approaches in hypertension management .
Qiangli Dingxuan Tablet
The combination of Qiangli Dingxuan tablet (QDT), a Chinese patent medicine, with amlodipine besylate demonstrated superior efficacy in reducing blood pressure compared to amlodipine monotherapy. This combination also improved traditional Chinese medicine symptom scores without severe adverse events, suggesting its potential as an adjunctive treatment for essential hypertension .
Conclusion
Amlodipine besylate interacts with various drugs, dietary supplements, and excipients, influencing its pharmacokinetic and therapeutic profiles. Understanding these interactions is essential for optimizing treatment regimens and ensuring patient safety. Integrative approaches combining amlodipine with traditional Chinese medicine or other antihypertensive agents show promise in enhancing therapeutic outcomes.
Sources and full results
Most relevant research papers on this topic